![]() | |
Clinical data | |
---|---|
Other names | Angorvid, Betamezid, Neomarsilid, Pivazide, Pivhydrazine |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.620 ![]() |
Chemical and physical data | |
Formula | C12H18N2O |
Molar mass | 206.289 g·mol−1 |
| |
(verify) |
Pivhydrazine (trade name Tersavid), also known as pivalylbenzhydrazine and pivazide, is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was formerly used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
| |
---|---|
|
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |